United States Pharmaceuticals

Annexon Inc (ANNX)

Track

Track

Annexon Inc. experienced three insider trading transactions over the past ninety days, all involving proposed sales by former director Thomas G. Wiggans. These divestments occurred following the company's recent earnings report, which showed an EPS miss. The stock has declined 15.1% during this period, reflecting broader market volatility for the healthcare firm.
Ticker: ANNX Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Annexon Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.7
WIGGANS THOMAS G Former Director Non-Executive Director
Transaction date
Proposed sale
Price
306.68
Quantity 96,422
Value US$2,829,211
2.7
WIGGANS THOMAS G Former Director Non-Executive Director
Transaction date
Proposed sale
Price
194.82
Quantity 52,761
Value US$4,792,251
2.7
WIGGANS THOMAS G Former Director Non-Executive Director
Transaction date
Proposed sale
Price
173.91
Quantity 43,071
Value US$4,019,001
3.3
Satter Muneer A Non-Executive Director
Transaction date
Purchase
Price
5.41
Quantity 613,497 +6.3%
Value US$3,319,019
Carson William H. Non-Executive Director
Transaction date
Planned purchase
Price
5.78
Quantity 8,000 +11.4%
Value US$46,240
Carson William H. Non-Executive Director
Transaction date
Planned purchase
Price
6.20
Quantity 8,000 +12.8%
Value US$49,600
Carson William H. Non-Executive Director
Transaction date
Planned purchase
Price
5.67
Quantity 8,000 +14.7%
Value US$45,360
3.3
Yednock Ted EVP & CHIEF INNOVATION OFFICER Officer
Transaction date
Sale
Price
5.42
Quantity 5,566 -3.5%
Value US$30,168
2.9
ARTIS DEAN RICHARD EVP & CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Sale
Price
5.43
Quantity 5,894 -3.2%
Value US$32,004
2.7
Lew Jennifer EVP & CHIEF FINANCIAL OFFICER Officer
Transaction date
Sale
Price
5.42
Quantity 5,565 -3.2%
Value US$30,162
2.9
Dananberg Jamie CHIEF MEDICAL OFFICER Officer
Transaction date
Sale
Price
5.43
Quantity 5,820 -4.5%
Value US$31,603
3.6
Overdorf Michael EVP & CHIEF BUSINESS OFFICER Officer
Transaction date
Sale
Price
5.42
Quantity 4,339 -2.3%
Value US$23,517
3.3
Yednock Ted Officer Officer
Transaction date
Proposed sale
Price
5.42
Quantity 5,566
Value US$30,181
2.9
ARTIS DEAN RICHARD Officer Officer
Transaction date
Proposed sale
Price
5.43
Quantity 5,894
Value US$31,980
3.6
Overdorf Michael Officer Officer
Transaction date
Proposed sale
Price
5.42
Quantity 4,339
Value US$23,530
2.9
Dananberg Jamie Officer Officer
Transaction date
Proposed sale
Price
5.43
Quantity 5,820
Value US$31,579
2.7
Lew Jennifer Officer Officer
Transaction date
Proposed sale
Price
5.42
Quantity 5,565
Value US$30,178
3.3
Yednock Ted EVP & CHIEF INNOVATION OFFICER Officer
Transaction date
Sale
Price
5.11
Quantity 7,857 -7.5%
Value US$40,149
3.6
Overdorf Michael EVP & CHIEF BUSINESS OFFICER Officer
Transaction date
Sale
Price
5.10
Quantity 6,225 -4.8%
Value US$31,747
2.7
Lew Jennifer EVP & CHIEF FINANCIAL OFFICER Officer
Transaction date
Sale
Price
5.11
Quantity 7,851 -6.5%
Value US$40,119
2.9
Dananberg Jamie CHIEF MEDICAL OFFICER Officer
Transaction date
Sale
Price
5.10
Quantity 5,290 -6.7%
Value US$26,979
2.9
ARTIS DEAN RICHARD EVP & CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Sale
Price
5.10
Quantity 5,290 -4.1%
Value US$26,979
2.7
Lew Jennifer Officer Officer
Transaction date
Proposed sale
Price
5.11
Quantity 7,851
Value US$40,119
2.9
ARTIS DEAN RICHARD Officer Officer
Transaction date
Proposed sale
Price
5.10
Quantity 5,290
Value US$26,990
3.3
Yednock Ted Officer Officer
Transaction date
Proposed sale
Price
5.11
Quantity 7,857
Value US$40,122
3.6
Overdorf Michael Officer Officer
Transaction date
Proposed sale
Price
5.10
Quantity 6,225
Value US$31,764
2.9
Dananberg Jamie Officer Officer
Transaction date
Proposed sale
Price
5.10
Quantity 5,290
Value US$26,990
Carson William H. Non-Executive Director
Transaction date
Planned purchase
Price
5.02
Quantity 4,115 +8.2%
Value US$20,657
3.3
Choi Jung Non-Executive Director
Transaction date
Purchase
Price
4.19
Quantity 33,000 +inf%
Value US$138,270
Carson William H. Non-Executive Director
Transaction date
Planned purchase
Price
4.47
Quantity 4,115 +8.9%
Value US$18,394
3.3
Satter Muneer A Non-Executive Director
Transaction date
Purchase
Price
4.28
Quantity 422,613 +4.5%
Value US$1,808,784
3.3
Satter Muneer A Non-Executive Director
Transaction date
Purchase
Price
4.48
Quantity 400,000 +4.5%
Value US$1,792,000
3.3
Satter Muneer A Non-Executive Director
Transaction date
Purchase
Price
3.94
Quantity 500,000 +5.9%
Value US$1,970,000
3.3
Satter Muneer A Non-Executive Director
Transaction date
Purchase
Price
3.18
Quantity 500,000 +6.3%
Value US$1,590,000
3.3
Satter Muneer A Non-Executive Director
Transaction date
Purchase
Price
2.99
Quantity 500,000 +6.8%
Value US$1,495,000
Carson William H. Non-Executive Director
Transaction date
Planned purchase
Price
3.17
Quantity 4,115 +9.8%
Value US$13,045
Carson William H. Non-Executive Director
Transaction date
Planned purchase
Price
3.05
Quantity 4,115 +10.8%
Value US$12,551
Carson William H. Non-Executive Director
Transaction date
Planned purchase
Price
2.09
Quantity 4,115 +12.2%
Value US$8,600
Carson William H. Non-Executive Director
Transaction date
Planned purchase
Price
2.43
Quantity 4,115 +13.8%
Value US$9,999
2.7
Lew Jennifer EVP & CHIEF FINANCIAL OFFICER Officer
Transaction date
Sale
Price
2.58
Quantity 1,117 -0.9%
Value US$2,882
3.3
Yednock Ted EVP & CHIEF INNOVATION OFFICER Officer
Transaction date
Sale
Price
2.58
Quantity 1,116 -1.1%
Value US$2,879
3.6
Overdorf Michael EVP & CHIEF BUSINESS OFFICER Officer
Transaction date
Sale
Price
2.61
Quantity 853 -0.6%
Value US$2,226
3.3
Yednock Ted Officer Officer
Transaction date
Proposed sale
Price
2.58
Quantity 1,116
Value US$2,881
3.6
Overdorf Michael Officer Officer
Transaction date
Proposed sale
Price
2.61
Quantity 853
Value US$2,226
2.7
Lew Jennifer Officer Officer
Transaction date
Proposed sale
Price
2.58
Quantity 1,117
Value US$2,881
Carson William H. Non-Executive Director
Transaction date
Planned purchase
Price
2.46
Quantity 4,115 +16.1%
Value US$10,123
3.3
Yednock Ted EVP & CHIEF INNOVATION OFFICER Officer
Transaction date
Sale
Price
2.91
Quantity 8,345 -12.0%
Value US$24,284
3.6
Overdorf Michael EVP & CHIEF BUSINESS OFFICER Officer
Transaction date
Sale
Price
2.95
Quantity 6,618 -7.1%
Value US$19,523
2.9
Dananberg Jamie CHIEF MEDICAL OFFICER Officer
Transaction date
Sale
Price
2.96
Quantity 5,521 -14.2%
Value US$16,342
2.9
ARTIS DEAN RICHARD EVP & CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Sale
Price
2.97
Quantity 5,515 -6.2%
Value US$16,380
2.7
Lew Jennifer EVP & CHIEF FINANCIAL OFFICER Officer
Transaction date
Sale
Price
2.92
Quantity 6,912 -8.2%
Value US$20,183
3.3
Yednock Ted Officer Officer
Transaction date
Proposed sale
Price
2.91
Quantity 8,345
Value US$24,321
2.7
Lew Jennifer Officer Officer
Transaction date
Proposed sale
Price
2.92
Quantity 8,338
Value US$24,319
2.9
ARTIS DEAN RICHARD Officer Officer
Transaction date
Proposed sale
Price
2.97
Quantity 5,515
Value US$16,359
2.9
Dananberg Jamie Officer Officer
Transaction date
Proposed sale
Price
2.96
Quantity 5,521
Value US$16,359
3.6
Overdorf Michael Officer Officer
Transaction date
Proposed sale
Price
2.95
Quantity 6,618
Value US$19,514
3.6
Overdorf Michael EVP & CHIEF BUSINESS OFFICER Officer
Transaction date
Sale
Price
2.99
Quantity 1,425 -1.5%
Value US$4,261
2.7
Lew Jennifer EVP & CHIEF FINANCIAL OFFICER Officer
Transaction date
Sale
Price
2.98
Quantity 1,786 -2.1%
Value US$5,322
3.1
Love Douglas PRESIDENT AND CEO Executive Director
Transaction date
Sale
Price
2.95
Quantity 5,021 -1.4%
Value US$14,812
3.3
Yednock Ted EVP & CHIEF INNOVATION OFFICER Officer
Transaction date
Sale
Price
2.99
Quantity 1,783 -2.5%
Value US$5,331
3.3
Yednock Ted Officer Officer
Transaction date
Proposed sale
Price
2.98
Quantity 1,783
Value US$5,316
3.1
Love Douglas Officer; Director Executive Director
Transaction date
Proposed sale
Price
2.95
Quantity 5,021
Value US$14,799
2.7
Lew Jennifer Officer Officer
Transaction date
Proposed sale
Price
2.98
Quantity 1,786
Value US$5,314
3.6
Overdorf Michael Officer Officer
Transaction date
Proposed sale
Price
2.99
Quantity 1,425
Value US$4,265
Carson William H. Non-Executive Director
Transaction date
Planned purchase
Price
5.33
Quantity 3,200 +14.3%
Value US$17,056
3.3
Yednock Ted EVP & CHIEF INNOVATION OFFICER Officer
Transaction date
Planned sale
Price
7.41
Quantity 5,408 -7.0%
Value US$40,073
3.3
Yednock Ted Officer Officer
Transaction date
Proposed sale
Price
7.41
Quantity 5,408
Value US$40,073
Carson William H. Non-Executive Director
Transaction date
Planned purchase
Price
5.97
Quantity 3,200 +16.7%
Value US$19,104
3.3
Yednock Ted EVP & CHIEF INNOVATION OFFICER Officer
Transaction date
Planned sale
Price
7.10
Quantity 4,500 -100.0%
Value US$31,950
3.3
Yednock Ted Officer Officer
Transaction date
Proposed sale
Price
7.10
Quantity 4,500
Value US$31,950
3.3
Yednock Ted EVP & CHIEF INNOVATION OFFICER Officer
Transaction date
Planned sale
Price
6.16
Quantity 5,500 -55.0%
Value US$33,880
3.3
Yednock Ted Officer Officer
Transaction date
Proposed sale
Price
6.16
Quantity 5,500
Value US$33,880
3.3
Yednock Ted EVP & CHIEF INNOVATION OFFICER Officer
Transaction date
Planned sale
Price
5.64
Quantity 5,500 -35.5%
Value US$31,020
3.3
Yednock Ted Officer Officer
Transaction date
Proposed sale
Price
5.64
Quantity 5,500
Value US$31,020
Carson William H. Non-Executive Director
Transaction date
Planned purchase
Price
5.48
Quantity 3,200 +20.0%
Value US$17,536
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-13 2026-08-13 PrS Proposed sale
2.7
WIGGANS THOMAS G

Former Director

Non-Executive Director
96,422
306.68
US$2,829,211 		96,422 306.68 US$2,829,211
2026-07-15 2026-07-15 PrS Proposed sale
2.7
WIGGANS THOMAS G

Former Director

Non-Executive Director
52,761
194.82
US$4,792,251 		52,761 194.82 US$4,792,251
2026-07-14 2026-07-14 PrS Proposed sale
2.7
WIGGANS THOMAS G

Former Director

Non-Executive Director
43,071
173.91
US$4,019,001 		43,071 173.91 US$4,019,001
2026-05-29 2026-05-28 B Purchase
3.3
Satter Muneer A
Non-Executive Director
613,497 +6.3%
5.41
US$3,319,019 		613,497 +6.3% 5.41 US$3,319,019
2026-05-13 2026-05-11 PP Planned purchase
Carson William H.
Non-Executive Director
8,000 +11.4%
5.78
US$46,240 		8,000 +11.4% 5.78 US$46,240
2026-04-14 2026-04-10 PP Planned purchase
Carson William H.
Non-Executive Director
8,000 +12.8%
6.20
US$49,600 		8,000 +12.8% 6.20 US$49,600
2026-03-12 2026-03-10 PP Planned purchase
Carson William H.
Non-Executive Director
8,000 +14.7%
5.67
US$45,360 		8,000 +14.7% 5.67 US$45,360
2026-03-04 2026-03-02 S Sale
3.3
Yednock Ted

EVP & CHIEF INNOVATION OFFICER

Officer
5,566 -3.5%
5.42
US$30,168 		5,566 -3.5% 5.42 US$30,168
2026-03-04 2026-03-02 S Sale
2.9
ARTIS DEAN RICHARD

EVP & CHIEF SCIENTIFIC OFFICER

Officer
5,894 -3.2%
5.43
US$32,004 		5,894 -3.2% 5.43 US$32,004
2026-03-04 2026-03-02 S Sale
2.7
Lew Jennifer

EVP & CHIEF FINANCIAL OFFICER

Officer
5,565 -3.2%
5.42
US$30,162 		5,565 -3.2% 5.42 US$30,162
2026-03-04 2026-03-02 S Sale
2.9
Dananberg Jamie

CHIEF MEDICAL OFFICER

Officer
5,820 -4.5%
5.43
US$31,603 		5,820 -4.5% 5.43 US$31,603
2026-03-04 2026-03-02 S Sale
3.6
Overdorf Michael

EVP & CHIEF BUSINESS OFFICER

Officer
4,339 -2.3%
5.42
US$23,517 		4,339 -2.3% 5.42 US$23,517
2026-03-02 2026-03-02 PrS Proposed sale
3.3
Yednock Ted

Officer

Officer
5,566
5.42
US$30,181 		5,566 5.42 US$30,181
2026-03-02 2026-03-02 PrS Proposed sale
2.9
ARTIS DEAN RICHARD

Officer

Officer
5,894
5.43
US$31,980 		5,894 5.43 US$31,980
2026-03-02 2026-03-02 PrS Proposed sale
3.6
Overdorf Michael

Officer

Officer
4,339
5.42
US$23,530 		4,339 5.42 US$23,530
2026-03-02 2026-03-02 PrS Proposed sale
2.9
Dananberg Jamie

Officer

Officer
5,820
5.43
US$31,579 		5,820 5.43 US$31,579
2026-03-02 2026-03-02 PrS Proposed sale
2.7
Lew Jennifer

Officer

Officer
5,565
5.42
US$30,178 		5,565 5.42 US$30,178
2026-02-20 2026-02-18 S Sale
3.3
Yednock Ted

EVP & CHIEF INNOVATION OFFICER

Officer
7,857 -7.5%
5.11
US$40,149 		7,857 -7.5% 5.11 US$40,149
2026-02-20 2026-02-18 S Sale
3.6
Overdorf Michael

EVP & CHIEF BUSINESS OFFICER

Officer
6,225 -4.8%
5.10
US$31,747 		6,225 -4.8% 5.10 US$31,747
2026-02-20 2026-02-18 S Sale
2.7
Lew Jennifer

EVP & CHIEF FINANCIAL OFFICER

Officer
7,851 -6.5%
5.11
US$40,119 		7,851 -6.5% 5.11 US$40,119
2026-02-20 2026-02-18 S Sale
2.9
Dananberg Jamie

CHIEF MEDICAL OFFICER

Officer
5,290 -6.7%
5.10
US$26,979 		5,290 -6.7% 5.10 US$26,979
2026-02-20 2026-02-18 S Sale
2.9
ARTIS DEAN RICHARD

EVP & CHIEF SCIENTIFIC OFFICER

Officer
5,290 -4.1%
5.10
US$26,979 		5,290 -4.1% 5.10 US$26,979
2026-02-18 2026-02-18 PrS Proposed sale
2.7
Lew Jennifer

Officer

Officer
7,851
5.11
US$40,119 		7,851 5.11 US$40,119
2026-02-18 2026-02-18 PrS Proposed sale
2.9
ARTIS DEAN RICHARD

Officer

Officer
5,290
5.10
US$26,990 		5,290 5.10 US$26,990
2026-02-18 2026-02-18 PrS Proposed sale
3.3
Yednock Ted

Officer

Officer
7,857
5.11
US$40,122 		7,857 5.11 US$40,122
2026-02-18 2026-02-18 PrS Proposed sale
3.6
Overdorf Michael

Officer

Officer
6,225
5.10
US$31,764 		6,225 5.10 US$31,764
2026-02-18 2026-02-18 PrS Proposed sale
2.9
Dananberg Jamie

Officer

Officer
5,290
5.10
US$26,990 		5,290 5.10 US$26,990
2026-01-02 2025-12-30 PP Planned purchase
Carson William H.
Non-Executive Director
4,115 +8.2%
5.02
US$20,657 		4,115 +8.2% 5.02 US$20,657
2025-12-03 2025-12-01 B Purchase
3.3
Choi Jung
Non-Executive Director
33,000 +inf%
4.19
US$138,270 		33,000 +inf% 4.19 US$138,270
2025-12-03 2025-12-01 PP Planned purchase
Carson William H.
Non-Executive Director
4,115 +8.9%
4.47
US$18,394 		4,115 +8.9% 4.47 US$18,394
2025-11-21 2025-11-21 B Purchase
3.3
Satter Muneer A
Non-Executive Director
422,613 +4.5%
4.28
US$1,808,784 		422,613 +4.5% 4.28 US$1,808,784
2025-11-21 2025-11-20 B Purchase
3.3
Satter Muneer A
Non-Executive Director
400,000 +4.5%
4.48
US$1,792,000 		400,000 +4.5% 4.48 US$1,792,000
2025-11-19 2025-11-19 B Purchase
3.3
Satter Muneer A
Non-Executive Director
500,000 +5.9%
3.94
US$1,970,000 		500,000 +5.9% 3.94 US$1,970,000
2025-11-19 2025-11-18 B Purchase
3.3
Satter Muneer A
Non-Executive Director
500,000 +6.3%
3.18
US$1,590,000 		500,000 +6.3% 3.18 US$1,590,000
2025-11-19 2025-11-17 B Purchase
3.3
Satter Muneer A
Non-Executive Director
500,000 +6.8%
2.99
US$1,495,000 		500,000 +6.8% 2.99 US$1,495,000
2025-10-31 2025-10-30 PP Planned purchase
Carson William H.
Non-Executive Director
4,115 +9.8%
3.17
US$13,045 		4,115 +9.8% 3.17 US$13,045
2025-10-02 2025-09-30 PP Planned purchase
Carson William H.
Non-Executive Director
4,115 +10.8%
3.05
US$12,551 		4,115 +10.8% 3.05 US$12,551
2025-09-04 2025-09-02 PP Planned purchase
Carson William H.
Non-Executive Director
4,115 +12.2%
2.09
US$8,600 		4,115 +12.2% 2.09 US$8,600
2025-08-01 2025-07-30 PP Planned purchase
Carson William H.
Non-Executive Director
4,115 +13.8%
2.43
US$9,999 		4,115 +13.8% 2.43 US$9,999
2025-07-16 2025-07-14 S Sale
2.7
Lew Jennifer

EVP & CHIEF FINANCIAL OFFICER

Officer
1,117 -0.9%
2.58
US$2,882 		1,117 -0.9% 2.58 US$2,882
2025-07-16 2025-07-14 S Sale
3.3
Yednock Ted

EVP & CHIEF INNOVATION OFFICER

Officer
1,116 -1.1%
2.58
US$2,879 		1,116 -1.1% 2.58 US$2,879
2025-07-16 2025-07-14 S Sale
3.6
Overdorf Michael

EVP & CHIEF BUSINESS OFFICER

Officer
853 -0.6%
2.61
US$2,226 		853 -0.6% 2.61 US$2,226
2025-07-14 2025-07-14 PrS Proposed sale
3.3
Yednock Ted

Officer

Officer
1,116
2.58
US$2,881 		1,116 2.58 US$2,881
2025-07-14 2025-07-14 PrS Proposed sale
3.6
Overdorf Michael

Officer

Officer
853
2.61
US$2,226 		853 2.61 US$2,226
2025-07-14 2025-07-14 PrS Proposed sale
2.7
Lew Jennifer

Officer

Officer
1,117
2.58
US$2,881 		1,117 2.58 US$2,881
2025-07-01 2025-06-30 PP Planned purchase
Carson William H.
Non-Executive Director
4,115 +16.1%
2.46
US$10,123 		4,115 +16.1% 2.46 US$10,123
2025-02-20 2025-02-18 S Sale
3.3
Yednock Ted

EVP & CHIEF INNOVATION OFFICER

Officer
8,345 -12.0%
2.91
US$24,284 		8,345 -12.0% 2.91 US$24,284
2025-02-20 2025-02-18 S Sale
3.6
Overdorf Michael

EVP & CHIEF BUSINESS OFFICER

Officer
6,618 -7.1%
2.95
US$19,523 		6,618 -7.1% 2.95 US$19,523
2025-02-20 2025-02-18 S Sale
2.9
Dananberg Jamie

CHIEF MEDICAL OFFICER

Officer
5,521 -14.2%
2.96
US$16,342 		5,521 -14.2% 2.96 US$16,342
2025-02-20 2025-02-18 S Sale
2.9
ARTIS DEAN RICHARD

EVP & CHIEF SCIENTIFIC OFFICER

Officer
5,515 -6.2%
2.97
US$16,380 		5,515 -6.2% 2.97 US$16,380
2025-02-20 2025-02-18 S Sale
2.7
Lew Jennifer

EVP & CHIEF FINANCIAL OFFICER

Officer
6,912 -8.2%
2.92
US$20,183 		6,912 -8.2% 2.92 US$20,183
2025-02-18 2025-02-18 PrS Proposed sale
3.3
Yednock Ted

Officer

Officer
8,345
2.91
US$24,321 		8,345 2.91 US$24,321
2025-02-18 2025-02-18 PrS Proposed sale
2.7
Lew Jennifer

Officer

Officer
8,338
2.92
US$24,319 		8,338 2.92 US$24,319
2025-02-18 2025-02-18 PrS Proposed sale
2.9
ARTIS DEAN RICHARD

Officer

Officer
5,515
2.97
US$16,359 		5,515 2.97 US$16,359
2025-02-18 2025-02-18 PrS Proposed sale
2.9
Dananberg Jamie

Officer

Officer
5,521
2.96
US$16,359 		5,521 2.96 US$16,359
2025-02-18 2025-02-18 PrS Proposed sale
3.6
Overdorf Michael

Officer

Officer
6,618
2.95
US$19,514 		6,618 2.95 US$19,514
2025-02-18 2025-02-13 S Sale
3.6
Overdorf Michael

EVP & CHIEF BUSINESS OFFICER

Officer
1,425 -1.5%
2.99
US$4,261 		1,425 -1.5% 2.99 US$4,261
2025-02-18 2025-02-13 S Sale
2.7
Lew Jennifer

EVP & CHIEF FINANCIAL OFFICER

Officer
1,786 -2.1%
2.98
US$5,322 		1,786 -2.1% 2.98 US$5,322
2025-02-18 2025-02-13 S Sale
3.1
Love Douglas

PRESIDENT AND CEO

Executive Director
5,021 -1.4%
2.95
US$14,812 		5,021 -1.4% 2.95 US$14,812
2025-02-18 2025-02-13 S Sale
3.3
Yednock Ted

EVP & CHIEF INNOVATION OFFICER

Officer
1,783 -2.5%
2.99
US$5,331 		1,783 -2.5% 2.99 US$5,331
2025-02-13 2025-02-13 PrS Proposed sale
3.3
Yednock Ted

Officer

Officer
1,783
2.98
US$5,316 		1,783 2.98 US$5,316
2025-02-13 2025-02-13 PrS Proposed sale
3.1
Love Douglas

Officer; Director

Executive Director
5,021
2.95
US$14,799 		5,021 2.95 US$14,799
2025-02-13 2025-02-13 PrS Proposed sale
2.7
Lew Jennifer

Officer

Officer
1,786
2.98
US$5,314 		1,786 2.98 US$5,314
2025-02-13 2025-02-13 PrS Proposed sale
3.6
Overdorf Michael

Officer

Officer
1,425
2.99
US$4,265 		1,425 2.99 US$4,265
2024-12-04 2024-12-02 PP Planned purchase
Carson William H.
Non-Executive Director
3,200 +14.3%
5.33
US$17,056 		3,200 +14.3% 5.33 US$17,056
2024-10-17 2024-10-15 PlS Planned sale
3.3
Yednock Ted

EVP & CHIEF INNOVATION OFFICER

Officer
5,408 -7.0%
7.41
US$40,073 		5,408 -7.0% 7.41 US$40,073
2024-10-15 2024-10-15 PrS Proposed sale
3.3
Yednock Ted

Officer

Officer
5,408
7.41
US$40,073 		5,408 7.41 US$40,073
2024-10-02 2024-10-01 PP Planned purchase
Carson William H.
Non-Executive Director
3,200 +16.7%
5.97
US$19,104 		3,200 +16.7% 5.97 US$19,104
2024-09-20 2024-09-19 PlS Planned sale
3.3
Yednock Ted

EVP & CHIEF INNOVATION OFFICER

Officer
4,500 -100.0%
7.10
US$31,950 		4,500 -100.0% 7.10 US$31,950
2024-09-19 2024-09-19 PrS Proposed sale
3.3
Yednock Ted

Officer

Officer
4,500
7.10
US$31,950 		4,500 7.10 US$31,950
2024-09-16 2024-09-12 PlS Planned sale
3.3
Yednock Ted

EVP & CHIEF INNOVATION OFFICER

Officer
5,500 -55.0%
6.16
US$33,880 		5,500 -55.0% 6.16 US$33,880
2024-09-12 2024-09-12 PrS Proposed sale
3.3
Yednock Ted

Officer

Officer
5,500
6.16
US$33,880 		5,500 6.16 US$33,880
2024-09-06 2024-09-05 PlS Planned sale
3.3
Yednock Ted

EVP & CHIEF INNOVATION OFFICER

Officer
5,500 -35.5%
5.64
US$31,020 		5,500 -35.5% 5.64 US$31,020
2024-09-05 2024-09-05 PrS Proposed sale
3.3
Yednock Ted

Officer

Officer
5,500
5.64
US$31,020 		5,500 5.64 US$31,020
2024-09-04 2024-09-03 PP Planned purchase
Carson William H.
Non-Executive Director
3,200 +20.0%
5.48
US$17,536 		3,200 +20.0% 5.48 US$17,536
Explore more

More insider trading research around Annexon Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America